Tag: Nasal high flow therapy
F&P sees increased demand due to COVID-19 surges
January 22, 2021HME News Staff
Coronavirus, Financial Results, Fisher & Paykel Healthcare, Nasal high flow therapy, Obstructive Sleep Apnea (OSA), Pandemic, Sleep Therapy
Sponsored Stories
How Advanced Diabetes Supply is Driving Value-Based Health Outcomes
By Advanced Diabetes SupplySOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office SupportCyber Siege: The Financial Vulnerability Healthcare Didn't See Coming
By Strategic Office SupportA new staffing model that delivers ready-to-work pros, boosting efficiency and lowering costs.
By Tactical Back OfficeJason Morin to help ‘drive mission’ at Analytix Solutions
NSF reviews sleep research, details impact of screens
Enos Home Medical recommits to sleep
Tomorrow Health 'magnifies impact’
Paragon Ventures enjoys front seat to industry change
Q&A: Barry Steelman amplifies NCART’s message
In brief: Dexcom study, test strip fraud, InfuSystem stock buy-back